Rabbit IgG anti-Sheep IgG (F(ab)2)-FITC, MinX none

Artikelnummer: DNA-SEC-182621
Artikelname: Rabbit IgG anti-Sheep IgG (F(ab)2)-FITC, MinX none
Artikelnummer: DNA-SEC-182621
Hersteller Artikelnummer: SEC-182621
Alternativnummer: DNA-SEC-182621
Hersteller: dianova
Wirt: Rabbit
Kategorie: Antikörper
Applikation: FLISA,FACS,IF
Spezies Reaktivität: Sheep
Immunogen: Sheep IgG F(ab)2 fragment
Konjugation: FITC
Alternative Synonym: rabbit anti-Sheep IgG F(ab)2 Antibody Fluorescein Conjugated, rabbit anti-Sheep IgG F(ab)2 FITC Conjugated Antibody
Format: IgG
Spezifität: IgG (F(ab')2)
Minimale Kreuzreaktivität (MinX): no cross-adsorbtion
Anti-Sheep IgG F(ab)2 Fluorescein Antibody generated in rabbit recognizes the dimeric Fab portion of the sheep IgG molecule. Sheep IgG F(ab)2 is a proteolytic fragment of immunoglobulin G (IgG) obtained by limited digestion with the enzyme pepsin under c
Klonalität: Polyclonal
Konzentration: 10.0 mg/mL
Isotyp: Ig
Puffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Reinheit: This product is an IgG fraction antibody purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above.  Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-fluorescein, anti-Rabbit Serum, Sheep IgG, Sheep IgG F(ab’)2 and Sheep Serum.  No reaction was noted against Sheep IgG F(c).
Formulierung: Lyophilized
Formel: 20 mM K3PO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% NaN3
Target-Kategorie: Sheep
Antibody Type: Secondary Antibody
Application Verdünnung: FLISA Dilution: 1:10,000 - 1:50,000, Flow Cytometry Dilution: 1:500 - 1:2,500, Fluorochrome Protein Value: 3.7, IF Microscopy Dilution: 1:1,000 - 1:5,000
Anwendungsbeschreibung: This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.